Bicara Therapeutics names Jeremy Bender, Christy Oliger to board

Reuters2026/07/28 12:30

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bicara Therapeutics appointed Jeremy Bender, Ph.D., MBA and Christy Oliger to its board.
Bender was CEO of Day One Biopharmaceuticals through its 2026 acquisition by Servier; he has more than 20 years of biotech strategy experience.
Oliger most recently served as senior vice president of Genentech’s Oncology Business Unit; she has more than 30 years of commercial experience.
Founding board member Kiran Mazumdar-Shaw retired from the board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607280830PRIMZONEFULLFEED9798971) on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bicara Therapeutics names Jeremy Bender, Christy Oliger to board

You may also like

Crypto prices